Viking Therapeutics (VKTX)

Viking Therapeutics (VKTX) Balance Sheet


Viking Therapeutics Balance Sheet

Viking Therapeutics's total assets for Q1 2024 were $967.52M, an increase of 162.56% from the previous quarter. VKTX total liabilities were $33.63M for the fiscal quarter, a 67.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 368.49M$ 168.53M$ 210.66M$ 256.50M$ 284.26M
Total Liabilities
$ 20.07M$ 23.21M$ 8.78M$ 12.16M$ 7.14M
Total Equity Gross Minority
$ 348.42M$ 145.32M$ 201.88M$ 244.34M$ 277.12M
Total Capitalization
$ 349.36M$ 146.58M$ 201.88M$ 244.34M$ 277.12M
Preferred Stock Equity
Capital Lease Obligations
---$ 359.00K$ 662.00K
Currency in USD

Viking Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis